| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |